Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Background: The combination of sofosbuvir (SOF), ribavirin (RBV) and peg-interferon-alfa-2a (peg-IFN-alfa-2a) as well as the combination of SOF and RBV for the treatment of patients infected with hepatitis c virus (HCV) has improved rates of sustained virological response (SVR) considerably in recen...

Full description

Saved in:
Bibliographic Details
Main Authors: Steinebrunner, Niels (Author) , Zimmerer, Thomas (Author) , Stremmel, Wolfgang (Author) , Eisenbach, Christoph (Author) , Antoni, Christoph Helmer (Author) , Pathil-Warth, Anita (Author)
Format: Article (Journal)
Language:English
Published: 04 August 2015
In: BMC gastroenterology
Year: 2015, Volume: 15
ISSN:1471-230X
DOI:10.1186/s12876-015-0328-9
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12876-015-0328-9
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12876-015-0328-9
Get full text
Author Notes:Niels Steinebrunner, Martin F. Sprinzl, Tim Zimmermann, Marcus A. Wörns, Thomas Zimmerer, Peter R. Galle, Wolfgang Stremmel, Christoph Eisenbach, Kerstin Stein, Christoph Antoni, Jörn M. Schattenberg and Anita Pathil
Search Result 1

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort by Steinebrunner, Niels (Author) , Zimmerer, Thomas (Author) , Stremmel, Wolfgang (Author) , Eisenbach, Christoph (Author) , Antoni, Christoph Helmer (Author) , Pathil-Warth, Anita (Author) ,

BioMed Central 2015

Get full text
Article (Journal) Book/Monograph Online Resource